Intellia Therapeutics Inc (NTLA)
CapEx to Revenue
23.62%
Quarterly · Period ending:
NTLA CapEx to Revenue
Latest reported23.62%period ending
Latest reported23.62%period ending
NTLA Quarterly CapEx/Revenue (0.00% → 23.62%)
Latest values, visible window
High-resolution chart · PNG
NTLA capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 23.6193% | |
| 0.525% | |
| 0.5474% | |
| 0.2104% | |
| 1.6778% | |
| 4.4205% | |
| 7.62% | |
| 14.038% | |
| 14.5465% | |
| 8.6608% | |
| -79.2906% | |
| 36.1241% | |
| 31.639% | |
| 30.3982% | |
| 28.8219% | |
| 31.9388% | |
| 28.3678% | |
| 411.1358% | |
| 22.3121% | |
| 62.9928% | |
| 44.855% | |
| 37.4244% | |
| 15.254% | |
| 3.1413% | |
| 6.3703% | |
| 6.5423% | |
| 23.5187% | |
| 16.4657% | |
| 8.4638% | |
| 14.6938% | |
| 20.203% | |
| 27.2138% | |
| 11.7233% | |
| 24.769% | |
| 35.9478% | |
| 30.887% | |
| 21.4974% | |
| 66.967% | |
| 60.5118% | |
| 12.4255% | |
| 27.2706% | |
| 56.7248% | |
| 50.1477% | |
| 35.6635% | |
| 42.6289% | |
| 40.1244% | |
| 0% | |
| 0% |